Top Versus Top: Amneal Pharmaceuticals, Inc. (NYSE:AMRX), Office Depot, Inc. (NASDAQ:ODP)

Amneal Pharmaceuticals, Inc. (NYSE:AMRX)

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) closed at $3.49 on the last trading session with an decrease of -3.32%, whereas, it previously closed at $3.61. The company has a market capitalization of $864.3 Million. The company traded shares of 2.41 Million on the trading day while its three month average volume stands at 1.79 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) produced diluted EPS of -2.76. The EPS estimate for next year as estimated by analysts is at 0.63 while EPS for next quarter is estimated at 0.09. Earnings per Share growth for this year is reported at 45.7, while the analysts estimated the EPS growth for next year at 0.63% and Earnings growth for next 5 years stands at -4.05% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -40%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is at 0 while the forward p/e is at 5.53. The P/S or Price to Sales ratio of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) stands at 0.53 and Price to Book or P/B for the most recent quarter stands at 2.14. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) are reported at 1.5 and 2.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Amneal Pharmaceuticals, Inc. (NYSE:AMRX) stands at -9, -104.8 and -14.7 respectively

The trailing twelve month Revenue of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is reported at 1.63 Billion with income of -361900000. The outstanding shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) are 247.65 Million. The institutional Ownership of the shares of 69.6 stands at 0.80%, this figure is decreased -3.87 in the last six months. The insider ownership for the shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is ticked at 1%, the figure is rose 100.88% in the last six months.

Some other important financial aspects to be discussed here for Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is the Mean Target Price estimated by the analysts which stands at 4.33. The 52 week high of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is placed at 14.65 and 52 week low is standing at 2.27.

Performance wise the shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) rose up 32.2% for the week, it also fell -26.68% for the monthly performance, while for the quarter it went up -24.3%. The shares increase 7.06% for the half year and plummeted for the Year-To-Date performance. The shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) shrinked -75.7% for the yearly performance.

Office Depot, Inc. (NASDAQ:ODP)

Office Depot, Inc. (NASDAQ:ODP) closed at $1.65 on the last trading session with an increase of 13.01%, whereas, it previously closed at $1.46. The company has a market capitalization of $899.25 Million. The company traded shares of 13.08 Million on the trading day while its three month average volume stands at 6.36 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Office Depot, Inc. (NASDAQ:ODP) produced diluted EPS of 0.18. The EPS estimate for next year as estimated by analysts is at 0.4 while EPS for next quarter is estimated at 0.07. Earnings per Share growth for this year is reported at 2, while the analysts estimated the EPS growth for next year at 0.4% and Earnings growth for next 5 years stands at 12.3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 18.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Office Depot, Inc. (NASDAQ:ODP) is at 9.22 while the forward p/e is at 4.09. The P/S or Price to Sales ratio of Office Depot, Inc. (NASDAQ:ODP) stands at 0.08 and Price to Book or P/B for the most recent quarter stands at 0.41. The Price to Free Cash Flow ratio or P/FCF is reported at 5.59. The quick ratio and the current ratio of Office Depot, Inc. (NASDAQ:ODP) are reported at 0.8 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Office Depot, Inc. (NASDAQ:ODP) stands at 1.3, 4.7 and 4 respectively

The trailing twelve month Revenue of Office Depot, Inc. (NASDAQ:ODP) is reported at 10.65 Billion with income of 99 Million. The outstanding shares of Office Depot, Inc. (NASDAQ:ODP) are 545 Million. The institutional Ownership of the shares of 93.1 stands at 0.80%, this figure is decreased -4.5 in the last six months. The insider ownership for the shares of Office Depot, Inc. (NASDAQ:ODP) is ticked at 1.2%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Office Depot, Inc. (NASDAQ:ODP) is the Mean Target Price estimated by the analysts which stands at 1.7. The 52 week high of Office Depot, Inc. (NASDAQ:ODP) is placed at 3.79 and 52 week low is standing at 1.23.

Performance wise the shares of Office Depot, Inc. (NASDAQ:ODP) fell down -6.25% for the week, it also fell -30.38% for the monthly performance, while for the quarter it went up -33.73%. The shares decrease -1.79% for the half year and plummeted for the Year-To-Date performance. The shares of Office Depot, Inc. (NASDAQ:ODP) shrinked -54.42% for the yearly performance.